BACKGROUND:Persons living with HIV (PLWH) who also use crack cocaine may have stressful, chaotic lives and typically do not engage in standard medical care that addresses a multitude of extenuating life circumstances. Yoga/meditation (YM) improves quality of life (QOL) and biomarkers of stress, but the effect of this intervention is almost unknown in PLWH, particularly those who use crack cocaine. OBJECTIVES: This pilot study sought to compare the feasibility and acceptability of 60-minute, twice-per-week sessions of YM for 2 months with those of no-contact control and to evaluate the effects of the intervention on QOL (according to the Short Form-36, Perceived Stress Scale [PSS], and Impact of Events Scale [IES]) and salivary cortisol and dehydroepiandrosterone sulfate (DHEA-S) among PLWH who use crack cocaine. DESIGN: Participants were randomly assigned to YM or no-contact control and were assessed at baseline, 2 months after the intervention, and 4 months' follow-up. RESULTS: The YM program was acceptable and feasible, with high overall attendance (89%) and individual participation in yoga sessions (83%). YM participants showed modest improvements on QOL. The PSS total score and the IES intrusion score improved significantly 2 months after the intervention, but cortisol and DHEA-S did not change. CONCLUSIONS: This pilot study showed a high level of feasibility and acceptability and modest effects on measures of QOL among PLWH who use crack cocaine. The results suggest utility of YM as a simple, safe, and inexpensive format to improve QOL in a population that has many medical difficulties and extenuating stressors.
RCT Entities:
BACKGROUND:Persons living with HIV (PLWH) who also use crack cocaine may have stressful, chaotic lives and typically do not engage in standard medical care that addresses a multitude of extenuating life circumstances. Yoga/meditation (YM) improves quality of life (QOL) and biomarkers of stress, but the effect of this intervention is almost unknown in PLWH, particularly those who use crack cocaine. OBJECTIVES: This pilot study sought to compare the feasibility and acceptability of 60-minute, twice-per-week sessions of YM for 2 months with those of no-contact control and to evaluate the effects of the intervention on QOL (according to the Short Form-36, Perceived Stress Scale [PSS], and Impact of Events Scale [IES]) and salivary cortisol and dehydroepiandrosterone sulfate (DHEA-S) among PLWH who use crack cocaine. DESIGN:Participants were randomly assigned to YM or no-contact control and were assessed at baseline, 2 months after the intervention, and 4 months' follow-up. RESULTS: The YM program was acceptable and feasible, with high overall attendance (89%) and individual participation in yoga sessions (83%). YM participants showed modest improvements on QOL. The PSS total score and the IES intrusion score improved significantly 2 months after the intervention, but cortisol and DHEA-S did not change. CONCLUSIONS: This pilot study showed a high level of feasibility and acceptability and modest effects on measures of QOL among PLWH who use crack cocaine. The results suggest utility of YM as a simple, safe, and inexpensive format to improve QOL in a population that has many medical difficulties and extenuating stressors.
Authors: S W Cole; B D Naliboff; M E Kemeny; M P Griswold; J L Fahey; J A Zack Journal: Proc Natl Acad Sci U S A Date: 2001-10-23 Impact factor: 11.205
Authors: Annette L Fitzpatrick; Leanna J Standish; Jose Berger; Jung G Kim; Carlo Calabrese; Nayak Polissar Journal: Altern Ther Health Med Date: 2007 Sep-Oct Impact factor: 1.305
Authors: Jessica L Montoya; Catherine M Jankowski; Kelly K O'Brien; Allison R Webel; Krisann K Oursler; Brook L Henry; David J Moore; Kristine M Erlandson Journal: AIDS Date: 2019-05-01 Impact factor: 4.177
Authors: Eugene M Dunne; Brittany L Balletto; Marissa L Donahue; Melissa M Feulner; Julie DeCosta; Dean G Cruess; Elena Salmoirago-Blotcher; Rena R Wing; Michael P Carey; Lori A J Scott-Sheldon Journal: Complement Ther Clin Pract Date: 2018-11-08 Impact factor: 2.446
Authors: Lisa A Uebelacker; Donnell Van Noppen; Geoffrey Tremont; Genie Bailey; Ana Abrantes; Michael Stein Journal: J Subst Abuse Treat Date: 2019-07-24
Authors: Craig R Rush; Justin C Strickland; Erika Pike; Christina R Studts; William W Stoops Journal: Drug Alcohol Depend Date: 2019-12-16 Impact factor: 4.492
Authors: Jorge Giménez-Meseguer; Juan Tortosa-Martínez; Juan M Cortell-Tormo Journal: Int J Environ Res Public Health Date: 2020-05-23 Impact factor: 3.390
Authors: Adria Quigley; Marie-Josée Brouillette; Jacqueline Gahagan; Kelly Kathleen O'Brien; Marilyn MacKay-Lyons Journal: J Int Assoc Provid AIDS Care Date: 2020 Jan-Dec